Share-based Payment Arrangement, Expense of Caris Life Sciences, Inc. from 30 Jun 2024 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Caris Life Sciences, Inc. quarterly Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2024 to 30 Sep 2025.
  • Caris Life Sciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $13,655,000, a 189% increase year-over-year.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)

Caris Life Sciences, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $13,655,000 +$8,932,000 +189% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $28,293,000 +$23,808,000 +531% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q3 2024 $4,723,000 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025 2025 Q3
Q2 2024 $4,485,000 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.